Art

J-GLOBAL ID：201302254018442333   Reference number：13A0565426

Maintenance Therapy with Intravesical Bacillus Calmette-Guerin in Patients with Intermediate- or High-risk Non-muscle-invasive Bladder Cancer

中等度リスクまたは高リスク筋層非浸潤性膀胱癌における膀胱内カルメット・ゲラン菌による維持療法

Author (11)： MUTO Satoru (Teikyo Univ. School of Medicine, Tokyo, JPN) ,  NAKAJIMA Akiko (Teikyo Univ. School of Medicine, Tokyo, JPN) ,  HORIUCHI Akira (Teikyo Univ. School of Medicine, Tokyo, JPN) ,  INOUE Masayuki (Teikyo Univ. School of Medicine, Tokyo, JPN) ,  CHINA Toshiyuki (Teikyo Univ. School of Medicine, Tokyo, JPN) ,  SAITO Keisuke (Teikyo Univ. School of Medicine, Tokyo, JPN) ,  ISOTANI Shuji (Teikyo Univ. School of Medicine, Tokyo, JPN) ,  HISASUE Shin-ichi (Teikyo Univ. School of Medicine, Tokyo, JPN) ,  YAMAGUCHI Raizo (Teikyo Univ. School of Medicine, Tokyo, JPN) ,  IDE Hisamitsu (Teikyo Univ. School of Medicine, Tokyo, JPN) ,  HORIE Shigeo (Teikyo Univ. School of Medicine, Tokyo, JPN)
Material： Japanese Journal of Clinical Oncology  (JJCO)
Volume： 43  Issue： 3  Page： 305-313  Publication year： Mar. 2013 
JST Material Number： W2222A  ISSN： 0368-2811  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： *bladder tumor ,...
Semi thesaurus term： relapse-free survival rate ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=13A0565426&from=J-GLOBAL&jstjournalNo=W2222A") }}

JST classification (2)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Urogenital tumors(=neoplasms)  (GM04000S)

Reference (22)：

• Sylvester RJ, van der Meijden AP, Oosterlinck W, et al. Predicting recurrence and progression in individual patients with stage Ta Ti bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006; 49: 466-77.
• Shelley MD, Mason MD, Kynaston H. Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses. Cancer Treat Rev 2010; 36: 195-205.
• Bale A, Bock PR. Intravesical bacille Calmette-Guerin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression. Urology 2004; 63: 682-6.
• Stenzl A, Cowan NC, De Santis M, et al. The updated EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 2009; 55: 815-25.
• Sylvester RJ, Van der Meijden AP, Lamm DL. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 2002; 168: 1964-70.

Terms in the title (5)： リスク ,  筋層非浸潤性膀胱癌 ,  膀胱 ,  菌 ,  維持療法